Filgotinib: Phase IIb final data

Final data from the double-blind, placebo-controlled, international Phase IIb DARWIN 2 trial in 283 patients with moderate to severe RA who had an inadequate response to methotrexate showed that once-daily filgotinib as monotherapy led